Join Now

Category Archives: BioUtah News

FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Atopic Dermatitis in Children Ages 2 to 5

FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Atopic Dermatitis in Children Ages 2 to 5

| Tagged | Comments Off on FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Atopic Dermatitis in Children Ages 2 to 5

2025 MedTech Conference Sponsored by AdvaMed

This week AdvaMed held its annual Medtech Conference, designed for those in the medical technology industry.

| Comments Off on 2025 MedTech Conference Sponsored by AdvaMed

Nucleus Grow Hosts State of Innovation Conference

The State of Innovation Conference, hosted by The Nucleus Institute, brought together entrepreneurs, investors, policymakers, and researchers to explore pathways, partnerships, and funding strategies for breakthrough technologies. The day began with keynote speaker Jerry Hollister, who spoke on federal innovation funding trends, followed by a panel highlighting Utah companies that had successfully leveraged SBIR/STTR awards, […]

| Comments Off on Nucleus Grow Hosts State of Innovation Conference

Nelson Labs’ 40th Anniversary Celebration Recap

Nelson Labs on October 1 celebrated a milestone 40th anniversary. Since its humble beginnings in 1985 in University of Utah’s Research Park, Nelson Labs has grown into a trusted, global leader of medical device and pharmaceutical testing.

| Tagged | Comments Off on Nelson Labs’ 40th Anniversary Celebration Recap

ARUP’s Advanced Practice Laboratory: A National Model for Bridging Education and Industry

September 30, Salt Lake City—In a groundbreaking collaboration between ARUP Laboratories and the University of Utah, the new Advanced Practice Clinical Laboratory Training Center opened its doors this week and took a bold step toward solving a nationwide shortage of clinical laboratory scientists. This state-of-the-art facility is more than a training site; it’s a model […]

| Tagged | Comments Off on ARUP’s Advanced Practice Laboratory: A National Model for Bridging Education and Industry

Glafabra Therapeutics, Uncommon Cures Collaborate to Advance Fabry Disease Therapy

Glafabra Therapeutics, Uncommon Cures Collaborate to Advance Fabry Disease Therapy

| Tagged | Comments Off on Glafabra Therapeutics, Uncommon Cures Collaborate to Advance Fabry Disease Therapy

Seek Labs Selected as Participant of ARPA-H Investor Catalyst Hub Spoke Network, Rapid Response Partnership Vehicle

Seek Labs Selected as Participant of ARPA-H Investor Catalyst Hub Spoke Network and Rapid Response Partnership Vehicle (RRPV)

| Tagged | Comments Off on Seek Labs Selected as Participant of ARPA-H Investor Catalyst Hub Spoke Network, Rapid Response Partnership Vehicle

Innovative Wearable for Pelvic Floor Health by Freyya Completes Clinical Study

Innovative Wearable for Pelvic Floor Health by Freyya Completes Clinical Study

| Tagged | Comments Off on Innovative Wearable for Pelvic Floor Health by Freyya Completes Clinical Study

Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy

Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy

| Tagged | Comments Off on Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy

Co-Diagnostics, Inc. Signs Strategic MOU with Partner in Kingdom of Saudi Arabia to Introduce Co-Dx™ PCR Platform to Middle East

The Memorandum of Understanding includes the formation of a Joint Venture in the Kingdom of Saudi Arabia for manufacturing and distribution of the Company’s upcoming Co-Dx™ PCR platform and other Co-Dx IP

| Tagged , | Comments Off on Co-Diagnostics, Inc. Signs Strategic MOU with Partner in Kingdom of Saudi Arabia to Introduce Co-Dx™ PCR Platform to Middle East

Renalytix Announces Collaboration with Tempus to Advance Intelligent Risk Assessment in Diabetic Kidney Disease

Definitive agreement to accelerate adoption of Renalytix’s FDA-approved, Medicare reimbursed kidneyintelX.dkd test to slow kidney disease progression and improve patient outcomes

| Tagged | Comments Off on Renalytix Announces Collaboration with Tempus to Advance Intelligent Risk Assessment in Diabetic Kidney Disease

KUDA THERAPEUTICS AWARDED $5.6M U.S. DoD GRANT TO BRING LEAD ONCOLOGY CANDIDATE INTO CLINIC

KUDA THERAPEUTICS AWARDED $5.6M U.S. DoD GRANT TO BRING LEAD ONCOLOGY CANDIDATE INTO CLINIC

| Tagged | Comments Off on KUDA THERAPEUTICS AWARDED $5.6M U.S. DoD GRANT TO BRING LEAD ONCOLOGY CANDIDATE INTO CLINIC